12.04.2024 - Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced two poster presentations on DAXXIFY for the treatment of cervical dystonia at the annual meeting of American Academy of Neurology (AAN), taking place April 13-18, 2024, in Denver, Colorado. . Seite 1
01.11.2023 - Revance Therapeutics, Inc. (RVNC) today announced that the company will release third quarter 2023 financial results on Wednesday, November 8, 2023, after the close of market. Revance will host a corresponding conference call and a live webcast at .